http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112294806-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate | 2020-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112294806-B |
| titleOfInvention | Application of 1-formyl-β-carboline derivatives in the preparation of anti-Newcastle disease virus drugs |
| abstract | The application of the 1-formyl-β-carboline derivative of the present invention in the preparation of anti-Newcastle disease virus drugs. The involved 1-formyl-β-carboline derivatives molecular structure is shown in formula (I), (II), (III); In vitro experimental studies have proved that the derivatives are effective in the early and late stages of Newcastle disease virus propagation. All can play an obvious inhibitory effect, and can play an antiviral effect on related cell lines, significantly inhibiting the proliferation of three different genotypes of NDV, and with the increase of concentration, the inhibition rate is higher; at the same time, it is toxic to DF-1 cells It is small and has the potential to be used alone or in combination with other drugs for anti-Newcastle disease virus. |
| priorityDate | 2020-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.